Sarepta Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| TUDOR INVESTMENT CORP ET AL | 11/14/2025 | 68.83 M | $63.35 M | 135,261.75% | 70.23% |
| BLACKROCK, INC. | 11/12/2025 | 13.20 M | $254.36 M | 8.95% | 13.47% |
| VANGUARD GROUP INC | 11/07/2025 | 10.82 M | $208.45 M | 18.09% | 11.04% |
| STATE STREET CORP | 11/14/2025 | 5.30 M | $102.23 M | 12.99% | 5.41% |
| ERSTE ASSET MANAGEMENT GMBH | 11/12/2025 | 2.69 M | $50.59 M | 65.65% | 2.74% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 2.65 M | $51.07 M | 324.38% | 2.70% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2025 | 2.14 M | $41.19 M | -1.11% | 2.18% |
| D. E. SHAW & CO., INC. | 11/14/2025 | 2.01 M | $38.68 M | -55.19% | 2.05% |
| UBS GROUP AG | 11/13/2025 | 1.99 M | $38.36 M | 297.24% | 2.03% |
| ABRDN PLC | 11/07/2025 | 1.98 M | $38.21 M | 59.59% | 2.02% |
| TWO SIGMA ADVISERS, LP | 11/14/2025 | 1.96 M | $37.73 M | -1.40% | 2.00% |
| MORGAN STANLEY | 11/14/2025 | 1.95 M | $37.54 M | 31.03% | 1.99% |
| FIRST TRUST ADVISORS LP | 11/12/2025 | 1.94 M | $37.38 M | 209.10% | 1.98% |
| BNP PARIBAS ARBITRAGE, SNC | 11/13/2025 | 1.78 M | $34.33 M | 44.39% | 1.82% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 11/13/2025 | 1.75 M | $33.63 M | 183.54% | 1.78% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 1.72 M | $33.17 M | -8.26% | 1.76% |
| AQR CAPITAL MANAGEMENT LLC | 11/14/2025 | 1.41 M | $26.40 M | 1,015.80% | 1.43% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 1.39 M | $26.81 M | -3.62% | 1.42% |
| LMR PARTNERS LLP | 11/14/2025 | 1.38 M | $26.64 M | 100.00% | 1.41% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 11/14/2025 | 1.37 M | $26.34 M | 187.87% | 1.39% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 11/14/2025 | 1.31 M | $25.22 M | -11.22% | 1.34% |
| FEDERATED HERMES, INC. | 11/03/2025 | 1.31 M | $25.22 M | 0.04% | 1.34% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 1.12 M | $21.51 M | 91.10% | 1.14% |
| CITIGROUP INC | 11/10/2025 | 1.02 M | $19.63 M | 384.46% | 1.04% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 990.87 K | $19.09 M | 449.73% | 1.01% |
| 683 CAPITAL MANAGEMENT, LLC | 11/14/2025 | 990.00 K | $19.08 M | 46.67% | 1.01% |
| AMUNDI | 11/14/2025 | 969.83 K | $22.56 M | 378.22% | 0.99% |
| INVESCO LTD. | 11/13/2025 | 832.64 K | $16.04 M | 241.97% | 0.85% |
| BRAIDWELL LP | 11/14/2025 | 832.10 K | $16.03 M | 100.00% | 0.85% |
| WHITEBOX ADVISORS LLC | 11/14/2025 | 810.80 K | $15.62 M | 13.46% | 0.83% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 803.06 K | $15.47 M | -12.41% | 0.82% |
| CAPITAL FUND MANAGEMENT S.A. | 11/13/2025 | 780.05 K | $15.03 M | 51.54% | 0.80% |
| BIOIMPACT CAPITAL LLC | 11/14/2025 | 700.00 K | $13.49 M | 117.60% | 0.71% |
| CAPTION MANAGEMENT, LLC | 11/14/2025 | 670.60 K | $12.92 M | -25.36% | 0.68% |
| JPMORGAN CHASE & CO | 11/26/2025 | 669.38 K | $12.90 M | 2.63% | 0.68% |
| CITADEL ADVISORS LLC | 11/14/2025 | 667.40 K | $12.86 M | 78.88% | 0.68% |
| DIMENSIONAL FUND ADVISORS LP | 11/12/2025 | 651.60 K | $12.55 M | -18.94% | 0.66% |
| NORTHERN TRUST CORP | 11/14/2025 | 638.78 K | $12.31 M | -15.90% | 0.65% |
| CITADEL ADVISORS LLC | 11/14/2025 | 610.60 K | $11.77 M | 84.86% | 0.62% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 609.15 K | $11.74 M | -9.61% | 0.62% |
| TANG CAPITAL MANAGEMENT LLC | 11/14/2025 | 600.00 K | $11.56 M | 42.76% | 0.61% |
| BANK OF NEW YORK MELLON CORP | 11/03/2025 | 590.27 K | $11.37 M | -9.09% | 0.60% |
| OPALEYE MANAGEMENT INC. | 11/14/2025 | 585.00 K | $11.27 M | 17.00% | 0.60% |
| CITADEL ADVISORS LLC | 11/14/2025 | 512.48 K | $9.88 M | 69.61% | 0.52% |
| VOLEON CAPITAL MANAGEMENT LP | 11/14/2025 | 501.14 K | $9.66 M | 4,651.51% | 0.51% |
| SG AMERICAS SECURITIES, LLC | 10/23/2025 | 499.62 K | $9.63 M | 1,229.03% | 0.51% |
| C WORLDWIDE GROUP HOLDING A/S | 11/05/2025 | 490.33 K | $9.45 M | 0.00% | 0.50% |
| PRINCIPAL FINANCIAL GROUP INC | 11/04/2025 | 468.07 K | $9.02 M | 109.06% | 0.48% |
| BALYASNY ASSET MANAGEMENT L.P. | 11/14/2025 | 383.00 K | $7.38 M | 32.07% | 0.39% |
| PUBLIC SECTOR PENSION INVESTMENT BOARD | 11/06/2025 | 381.17 K | $7.35 M | 100.00% | 0.39% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Sarepta Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 571 institutional investors and hedge funds held shares of Sarepta Therapeutics, Inc.. The most heavily invested institutionals were:
TUDOR INVESTMENT CORP ET AL: 68.83 M
BlackRock, Inc.: 13.2 M
VANGUARD GROUP INC: 10.82 M
STATE STREET CORP: 5.3 M
Erste Asset Management GmbH: 2.69 M
RENAISSANCE TECHNOLOGIES LLC: 2.65 M
158.86% of Sarepta Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 179.66 M shares in the last 24 months. This purchase volume represents approximately $4.07 B in transactions.